Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
More stories
Workers' Comp
Article
How Naloxone Can Help Fight the Opioid Crisis
Workers' Comp
Blog
Morphine Equivalent Dose (MED) Continues to Decline
In 2018 Coventry’s pharmacy benefit management solution, First Script®, saw a 7.8% decrease in average MED per prescription for its retail and mail
Mitchell
Article
Humanizing the Collision Claims Experience in the Digital Age
Today’s customers have high expectations.
Mitchell
News Release
Arizona Industrial Commission Proposes Changes to Pharmacy Fee Schedule
Of particular interest are the proposed changes to the pharmacy reimbursement sections.
Mitchell
News Release
Texas Joins Ranks of States with Opioid Limits
The Texas legislature passed HB 2174, implementing several policy changes related to the prescribing of opioids, including new prescribing limits f
Mitchell
News Release
Property & Casualty in the Age of Humane Automation
As Mitchell President and CEO Alex Sun writes in Carrier Management, “Humane automation is the notion that as companies add artificial intelligence